10.0 modified release formulaiton

0.0(0)
studied byStudied by 0 people
0.0(0)
full-widthCall Kai
learnLearn
examPractice Test
spaced repetitionSpaced Repetition
heart puzzleMatch
flashcardsFlashcards
GameKnowt Play
Card Sorting

1/20

encourage image

There's no tags or description

Looks like no tags are added yet.

Study Analytics
Name
Mastery
Learn
Test
Matching
Spaced

No study sessions yet.

21 Terms

1
New cards

oral emdications are designed to deliver immediate release/ conventional drug delivery

A typical example is taking paracetamol (acetaminophen) for headaches, where the tablet or capsule quickly disintegrates in the stomach, allowing the drug to be absorbed in the gastrointestinal tract and providing fast relief.

2
New cards

However a rapid onset of action may not be ideal,

modifying the drug release profile is required to slow down the release or extend the drug's effects (e.g., over 24 hours).

These advanced formulations are referred to as oral modified-release (MR) drug delivery systems.

3
New cards

modified release drug delivery from a solid oral dosage form, tablet/

pellet/

capsule

with specific aim to delivering drug at desired rates predefined time points or specific sites in the GI tract

4
New cards
<p>ooral tablers are classified based on drug release from table</p>

ooral tablers are classified based on drug release from table

  • immediate release

  • mofidied release

    • rapid release

    • prolonged release

    • delayed release

5
New cards

Rapid-release tablets are used for drug release and absorption, generally in the sublingual or buccal area.

They are manufactured to ensure ultra-rapid drug release, allowing the drug to pass from the oral cavity into the bloodstream without having to pass through the stomach, as with conventional tablets.

6
New cards

Prolonged-release dosage formulations allow a reduction in dosing frequency

y compared with when the drug is present in an immediate-release dosage form (i.e., drug plasma levels are sustained for longer periods).

7
New cards

These are also known as prolonged-release or sustained-release dosage forms and are also referred to as controlled-release dosage forms

Extended-release systems which are retained in the stomach are known as gastroretentive systems.

<p><span><span>Extended-release systems which are retained in the stomach are known as gastroretentive systems.</span></span></p>
8
New cards

Delayed-release dosage forms release the drug at a time later than immediately after administration

(i.e., there is a significant lag time between a patient taking a medicine and the drug releasing from the dosage form).

9
New cards

Site-specific targeting is a type of delayed-release formulation

that aims to target specific regions of the gastrointestinal tract, such as the small intestine or colon.

10
New cards

For example, gastro-resistant dosage forms are designed to have a delayed-release mechanism,

which enables the release of a drug when exposed to a specific environmental pH.

11
New cards

A common example of this type of dosage form ensures that the drug is not released in the acidic stomach compartment

but in the higher-pH environment of the small intestine. Such products may also be known as enteric dosage forms.

12
New cards

clinical application of prolonged release oral drug delivery

  • keeping the drug in the theraputic range

  • reducing side effects

  • improving patient adherence3

13
New cards

keeping the drug in the theraputic range

When an immediate-release drug is ingested the plasma concentration will increase and then eventually decrease as the drug is metabolised.

14
New cards
<p><span><span>The plasma concentrations of drug will go through cycles of peaks and troughs.</span></span></p>

The plasma concentrations of drug will go through cycles of peaks and troughs.

An extended-release formulation can avoid the peaks and troughs, keeping the drug at therapeutic levels for a longer time

15
New cards

For many chronic illnesses, symptom breakthrough can occur if the blood concentration falls below the minimum effective concentration,

e.g., in depressive illness. This minimum level can also be critical for control of pain; consequently, drugs such as opioid analgesics are often given as extended-release preparations.

16
New cards

reducing side effects

Immediate-release formulations can often have a high maximum concentration in the blood (C max).

17
New cards

If C max is above the maximum safe concentration of the drug,

adverse events may be more likely.

18
New cards

Using prolonged-release formulations to reduce C max

reduce the incidence and severity of the side effects of some drugs.

19
New cards

Additionally, some drugs such as potassium chloride can be irritating to the gastrointestinal tract if delivered in an immediate-release bolus.

A slow, sustained release is required to minimise the occurrence of irritant concentrations.

20
New cards

imrpoving patient adherence

significant driver for developing a prolonged-release dosage form is the goal of achieving once-daily dosing

21
New cards

Once-daily dosing is considered to be more convenient for patients

and reduces the risk of missed doses throughout the day.